| GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts RM Sterner, R Sakemura, MJ Cox, N Yang, RH Khadka, CL Forsman, ... Blood, The Journal of the American Society of Hematology 133 (7), 697-709, 2019 | 530 | 2019 |
| Comparison of early and late toxic effects of sulfur mustard in Iranian veterans M Balali‐Mood, M Hefazi Basic & clinical pharmacology & toxicology 99 (4), 273-282, 2006 | 376 | 2006 |
| The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning M Balali‐Mood, M Hefazi Fundamental & clinical pharmacology 19 (3), 297-315, 2005 | 368 | 2005 |
| Long‐term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans M Balali‐Mood, M Hefazi, M Mahmoudi, E Jalali, D Attaran, M Maleki, ... Fundamental & clinical pharmacology 19 (6), 713-721, 2005 | 239 | 2005 |
| Late respiratory complications of mustard gas poisoning in Iranian veterans M Hefazi, D Attaran, M Mahmoudi, M Balali-Mood Inhalation toxicology 17 (11), 587-592, 2005 | 129 | 2005 |
| Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans M Mahmoudi, M Hefazi, M Rastin, M Balali-Mood International immunopharmacology 5 (9), 1479-1485, 2005 | 106 | 2005 |
| Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications M Etezad‐Razavi, M Mahmoudi, M Hefazi, M Balali‐Mood Clinical & experimental ophthalmology 34 (4), 342-346, 2006 | 105 | 2006 |
| Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16–20 years after exposure M Hefazi, M Maleki, M Mahmoudi, A Tabatabaee, M Balali‐Mood International journal of dermatology 45 (9), 1025-1031, 2006 | 104 | 2006 |
| Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma R Sakemura, M Hefazi, EL Siegler, MJ Cox, DP Larson, MJ Hansen, ... Blood, The Journal of the American Society of Hematology 139 (26), 3708-3721, 2022 | 72 | 2022 |
| Safety and efficacy of fecal microbiota transplant for recurrent Clostridium difficile infection in patients with cancer treated with cytotoxic chemotherapy: a single … M Hefazi, MM Patnaik, WJ Hogan, MR Litzow, DS Pardi, S Khanna Mayo Clinic Proceedings 92 (11), 1617-1624, 2017 | 71 | 2017 |
| Recent advances in the biology and treatment of T cell acute lymphoblastic leukemia M Hefazi, MR Litzow Current hematologic malignancy reports 13, 265-274, 2018 | 66 | 2018 |
| Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia MJ Cox, F Lucien, R Sakemura, JC Boysen, Y Kim, P Horvei, CM Roman, ... Molecular Therapy 29 (4), 1529-1540, 2021 | 64 | 2021 |
| Late relapses in patients with diffuse large B-cell lymphoma treated with immunochemotherapy Y Wang, U Farooq, BK Link, MC Larson, RL King, MJ Maurer, C Allmer, ... Journal of Clinical Oncology 37 (21), 1819-1827, 2019 | 63 | 2019 |
| Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans M Balali-Mood, R Afshari, R Zojaji, H Kahrom, M Kamrani, D Attaran, ... Human & experimental toxicology 30 (9), 1141-1149, 2011 | 55 | 2011 |
| Vancomycin‐resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic … M Hefazi, M Damlaj, HB Alkhateeb, DK Partain, R Patel, RR Razonable, ... Transplant Infectious Disease 18 (6), 913-920, 2016 | 51 | 2016 |
| Safety and efficacy of infliximab therapy in the setting of steroid-refractory acute graft-versus-host disease FF Yalniz, M Hefazi, K McCullough, MR Litzow, WJ Hogan, R Wolf, ... Biology of Blood and Marrow Transplantation 23 (9), 1478-1484, 2017 | 42 | 2017 |
| Evaluation of delayed toxic effects of sulfur mustard poisoning in severely intoxicated Iranian veterans: a cross-sectional study M Balali-Mood, M Hefazi, M Mahmoudi, I Jalali, D Attaran, M Maleki, ... J Med CBR Def 3, 0301, 2005 | 39 | 2005 |
| Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia M Hefazi, MR Litzow Blood and lymphatic cancer: targets and therapy, 47-61, 2018 | 34 | 2018 |
| Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes P Sharma, SS Shinde, M Damlaj, M Hefazi Rorghabeh, SK Hashmi, ... Leukemia & lymphoma 58 (4), 872-881, 2017 | 34 | 2017 |
| Fludarabine-busulfan reduced-intensity conditioning in comparison with fludarabine-melphalan is associated with increased relapse risk in spite of pharmacokinetic dosing M Damlaj, HB Alkhateeb, M Hefazi, DK Partain, S Hashmi, DA Gastineau, ... Biology of Blood and Marrow Transplantation 22 (8), 1431-1439, 2016 | 31 | 2016 |
